Header Logo

Connection

Anthony Rothschild to Psychotropic Drugs

This is a "connection" page, showing publications Anthony Rothschild has written about Psychotropic Drugs.
Connection Strength

2.288
  1. Rothschild AJ. Psychopharmacology: Back to Basics. J Clin Psychopharmacol. 2022 Jan-Feb 01; 42(1):1-2.
    View in: PubMed
    Score: 0.727
  2. Rothschild AJ. The Pitfalls of Psychotropic Polypharmacy. J Clin Psychopharmacol. 2021 May-Jun 01; 41(3):227-232.
    View in: PubMed
    Score: 0.694
  3. Rothschild AJ, Parikh SV, Hain D, Law R, Thase ME, Dunlop BW, DeBattista C, Conway CR, Forester BP, Shelton RC, Macaluso M, Brown K, Lewis D, Gutin A, Jablonski MR, Greden JF. Clinical validation of combinatorial pharmacogenomic testing and single-gene guidelines in predicting psychotropic medication blood levels and clinical outcomes in patients with depression. Psychiatry Res. 2021 02; 296:113649.
    View in: PubMed
    Score: 0.676
  4. Rothschild AJ. Advancing the Development of New Medications to Treat Psychiatric Illness. J Clin Psychopharmacol. 2022 Nov-Dec 01; 42(6):517.
    View in: PubMed
    Score: 0.192
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.